FERRING Pharmaceuticals REKOVELLE Reusable Injection Pen Singapura - Inggris - HSA (Health Sciences Authority)

ferring pharmaceuticals rekovelle reusable injection pen

ferring pharmaceuticals private limited - obstetrics & gynaecology - reusable injection pen intended for the administration of subcutaneous injections of rekovelle provided by ferring pharmaceuticals a/s.

Ambica International Corporation Promeddazole Metronidazole Filipina - Inggris - FDA (Food And Drug Administration)

ambica international corporation promeddazole metronidazole

akums drugs & pharmaceuticals ltd. (plant iii-injectables) - drug - metronidazole - promeddazole

None

Dosage 500 mg (equivalent to 562.43 mg Sodium ascorbate)  1,000 IU/10 mg (equivalent to 70 mg Zinc gluconate)

Dosage Filipina - Inggris - FDA (Food And Drug Administration)

none dosage 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

Clobazam Essential Pharmaceuticals 1 mg/ml oral suspension Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

clobazam essential pharmaceuticals 1 mg/ml oral suspension

essential pharmaceuticals limited - clobazam - oral suspension - 1 milligram(s)/millilitre - clobazam

Pharmaceutical management support software Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmaceutical management support software

pfizer australia pty ltd - 61215 - pharmaceutical management support software - clopine central is a web-based application intended for the remote monitoring of agranulocytosis or neutropenia, via completion of regular blood testing, as reported by medical practitioners for patients affected by treatment resistant schizophrenia.

Pharmaceutical management support software, professional-use Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pharmaceutical management support software, professional-use

abbvie pty ltd - 64410 - pharmaceutical management support software, professional-use - manage-pd device is a software-based tool intended to support healthcare providers in the identification of patients with parkinson's disease (pd) uncontrolled on oral medications.

Febuxostat Mylan Uni Eropa - Inggris - EMA (European Medicines Agency)

febuxostat mylan

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout preparations - febuxostat mylan is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (tls).febuxostat mylan is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).febuxostat mylan is indicated in adults.

Cinacalcet Mylan Uni Eropa - Inggris - EMA (European Medicines Agency)

cinacalcet mylan

mylan pharmaceuticals limited - cinacalcet hydrochloride - hyperparathyroidism, secondary; hypercalcemia - calcium homeostasis - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy.cinacalcet mylan may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate.reduction of hypercalcaemia in patients with:parathyroid carcinomaprimary hpt for whom parathyroidectomywould be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated. 

Duloxetine Mylan Uni Eropa - Inggris - EMA (European Medicines Agency)

duloxetine mylan

mylan pharmaceuticals limited - duloxetine - neuralgia; diabetic neuropathies; depressive disorder, major; anxiety disorders - psychoanaleptics, - treatment of major depressive disorder;treatment of diabetic peripheral neuropathic pain;treatment of generalised anxiety disorder;duloxetine mylan is indicated in adults.

Deferasirox Mylan Uni Eropa - Inggris - EMA (European Medicines Agency)

deferasirox mylan

mylan pharmaceuticals limited - deferasirox - iron overload; beta-thalassemia - iron chelating agents - deferasirox mylan is indicated forthe treatment of chronic iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with beta thalassaemia major aged 6 years and olderthe treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:in paediatric patients with beta thalassaemia major with iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years,in adult and paediatric patients with beta thalassaemia major with iron overload due to infrequent blood transfusions (